HealthCare Global Enterprises Ltd
Press release on Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 06 Aug 2026, 08:45 PM IST · BSE ID: 41916952-0291-4702-bcbe-7a7772c7ddae
View Original BSE Filing (PDF)
💡
In Simple Terms
HealthCare Global reported increased quarterly earnings with higher revenue and profit, driven by expanded hospital operations.
🤖 AI Summary
- HealthCare Global's consolidated revenue from operations for Q1 FY27 increased 13% YoY to INR 6,951 Million.
- Adjusted EBITDA for Q1 FY27 rose 20% YoY to INR 1,339 Million, with margins at 19.4%.
- Adjusted PAT for Q1 FY27 saw a 190% YoY increase, reaching INR 138 Million.
- The company commissioned a new 120+ bed hospital in North Bangalore in May 2026 and added 121 operational beds across its network.
- International business revenue grew approximately 9% YoY to INR 208 Million in Q1 FY27.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Consolidated)
INR 6,951 Mn
13%
Adjusted EBITDA (Consolidated)
INR 1,339 Mn
20%
Adjusted EBITDA Margin (Consolidated)
19.4%
Adjusted PAT (Consolidated)
INR 138 Mn
190%
North Bangalore Hospital Contribution (Q1 FY27)
INR 67 Mn
International Business Revenue (Q1 FY27)
INR 208 Mn
~9%
Fertility Business Revenue (Q1 FY27, before divestment)
INR 169 Mn
🏢 How This Affects the Company
The 13% YoY revenue growth and commissioning of the North Bangalore hospital, which contributed INR 67 Million, expands the company's oncology network and market reach.
Adjusted EBITDA grew 20% YoY to INR 1,339 Million with margin improvement to 19.4%, indicating enhanced operational efficiency and profitability.
The addition of 121 operational beds, including 56 at North Bangalore, and the commissioning of advanced medical equipment like the MR Linac, expand the company's service capacity and clinical capabilities.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with consolidated revenue up 13% YoY and Adjusted PAT up 190% YoY, reflecting business expansion and profitability.
🔍
Management Signal
Management's statements indicate a strategic focus on expanding network capacity, increasing high-complexity oncology care, and improving operational efficiency for sustained profitable growth.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor North Bangalore hospital's contribution and profitability.
Progress of insurance empanelment for the new North Bangalore facility.
Updates on capacity expansion and commissioning of new LINACs or robotic systems.
MEDIUM RISK
While growth is strong, new facilities like North Bangalore incur initial losses (INR 70 Mn), requiring close monitoring.
💡 Investor Takeaway
HealthCare Global reported Q1 FY27 consolidated revenue from operations of INR 6,951 Million, up 13% YoY, and Adjusted PAT of INR 138 Million, a 190% YoY increase. Adjusted EBITDA grew 20% YoY to INR 1,339 Million, with margins at 19.4%. The company added 121 operational beds and commissioned its North Bangalore hospital.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated Adjusted PAT increased by 190% YoY, from INR 47 Million in Q1 FY26 to INR 138 Million in Q1 FY27.
- Adjusted EBITDA margin improved by 121 bps to 19.4% in Q1 FY27 from 18.2% in Q1 FY26, alongside 20% YoY EBITDA growth.
⚠️ Concerns
- Adjusted PAT declined by 59.6% QoQ from INR 341 Million in Q4 FY26 to INR 138 Million in Q1 FY27.
- North Bangalore hospital recorded a loss of INR 70 Million in Q1 FY27, which was excluded from Adjusted EBITDA calculations.
📅 Company Track Record
Previous filings indicated HealthCare Global's Q1 FY27 profit was up 61.74% to Rs. 558 Lakhs YoY (as per a related filing on 2026-08-06). In March 2026, the board approved deploying INR 253.66 Crore rights issue proceeds into two profitable cancer subsidiaries, aiming for 85% Vizag ownership and a debt-free NCHRI by Q1 FY27.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was HealthCare Global Enterprises' consolidated revenue in Q1 FY27?
HealthCare Global Enterprises reported consolidated revenue from operations of INR 6,951 Million in Q1 FY27, reflecting a 13% year-on-year growth.
How much did HealthCare Global Enterprises' Adjusted PAT increase in Q1 FY27?
Adjusted PAT for HealthCare Global Enterprises increased by 190% year-on-year to INR 138 Million in Q1 FY27, compared to INR 47 Million in Q1 FY26.
What was the Adjusted EBITDA and its margin for HealthCare Global Enterprises in Q1 FY27?
HealthCare Global Enterprises reported an Adjusted EBITDA of INR 1,339 Million in Q1 FY27, up 20% year-on-year, with a margin of 19.4%.
What was the contribution of the North Bangalore hospital to HealthCare Global's Q1 FY27 revenue?
The newly commissioned North Bangalore hospital contributed INR 67 Million to HealthCare Global Enterprises' revenue in Q1 FY27.
How many new operational beds did HealthCare Global Enterprises add in Q1 FY27?
HealthCare Global Enterprises added a total of 121 operational beds during Q1 FY27, including 56 beds at North Bangalore, 26 at Ranchi, and 19 at Borivali.
Questions based on this BSE filing only. For information purposes.